View Financial HealthThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsCarebook Technologies 配当と自社株買い配当金 基準チェック /06Carebook Technologies配当金を支払った記録がありません。主要情報n/a配当利回り0%バイバック利回り総株主利回り0%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Feb 25+ 1 more updateCarebook Technologies' Common Shares to be Delisted from the TSX Venture Exchange at the Close of Trading on or about February 25, 2025Carebook Technologies Inc. (‘Carebook’ or the ‘Company’) announced the closing of the previously announced plan of arrangement (the ‘Transaction’) pursuant to which UIL Limited (‘UIL’) has acquired all of the common shares of Carebook (the ‘Common Shares’) not already owned by UIL and its affiliates or associates, at a price of $0.10 per Common Share (the ‘Consideration’), for aggregate consideration to the shareholders of Carebook (other than UIL and its associates or associates) of $4,170,618.90. The Transaction received overwhelming support from the Company's shareholders at a special meeting held on February 18, 2025, and the Transaction received final court approval on February 20, 2025. As a result of the Transaction, the Common Shares are expected to be delisted from the TSX Venture Exchange (‘TSXV’) at the close of trading on or about February 25, 2025. The Company also intends to submit an application to cease to be a reporting issuer under applicable Canadian securities laws and to otherwise terminate the Company's public reporting requirements.お知らせ • Jan 03UIL Limited (LSE:UTL), managed by ICM Limited entered into an arrangement agreement to acquire remaining 40.6% stake in Carebook Technologies Inc. (TSXV:CRBK) from Medtech Investment, L.P and others for CAD 4.2 million.UIL Limited (LSE:UTL), managed by ICM Limited entered into an arrangement agreement to acquire remaining 40.6% stake in Carebook Technologies Inc. (TSXV:CRBK) from Medtech Investment, L.P and others for CAD 4.2 million on January 2, 2025. UIL will acquire all of the common shares (the "Common Shares") in the capital of Carebook, other than those Common Shares already owned by UIL or its affiliates and associates, by way of a plan of arrangement (the "Arrangement"). Pursuant to the Arrangement, holders of Common Shares, other than those Common Shares already owned by UIL or its affiliates and associates, will receive CAD 0.10 per Common Share (the "Consideration"). The Consideration represents a premium of approximately 122%, to the closing price of the Common Shares of CAD 0.045 on the TSX Venture Exchange (the "TSXV") on January 2, 2025, the last trading day prior to the announcement of the Arrangement. Completion of the Arrangement is subject to court approval and various closing conditions, including the approval of at least (i) two-thirds (66 2/3%) of the votes cast by shareholders present in person or represented by proxy at the special meeting of the shareholders to be called to approve the Arrangement (the "Special Meeting") (each holder of Common Shares being entitled to one vote per Common Share) and (ii) the approval of a simple majority of the holders of Common Shares present in person or represented by proxy at the Special Meeting, excluding the votes of UIL and its affiliates and associates and any other shareholders required to be excluded for purposes of the "minority approval" requirement under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101") in the context of a "business combination" (the "Minority Shareholders"). Further details regarding applicable voting requirements will be contained in a management information circular to be filed on SEDAR+ at www.sedarplus.com and mailed to Carebook's shareholders in connection with the Special Meeting to approve the Arrangement. The signing of the Arrangement Agreement and the approval of the Arrangement followed the unanimous approval of the board of directors of the Company (the "Board") (with Alasdair Younie abstaining) following the unanimous recommendation of a committee of independent directors (the "Special Committee") of the Board. The Arrangement is expected to close in the first quarter of 2025, subject to the satisfaction of customary closing conditions. The Arrangement will be completed pursuant to a court-approved plan of arrangement under section 192 of the Canada Business Corporations Act and is subject to satisfaction of customary closing conditions for transactions of this nature, including court approval and the approval of the shareholders of Carebook, as further set out below. Immediately following the completion of the Arrangement, the Common Shares will be delisted from the TSXV and it is anticipated that the Company will make an application to cease to be a reporting issuer, following the approval of which, the Company will no longer be subject to the reporting requirements of applicable Canadian securities legislation. BDO Canada LLP is acting as financial advisor and fairness opinion provider to the Special Committee, and Stikeman Elliott LLP is acting as legal advisor to the Special Committee and the Company. Norton Rose Fulbright Canada LLP is acting as legal advisor to UIL on the proposed transaction.お知らせ • Nov 08Carebook Technologies Inc. to Report Q3, 2024 Results on Nov 15, 2024Carebook Technologies Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 15, 2024お知らせ • Aug 22Carebook Technologies Inc. Provides Earnings Guidance for the Fiscal Year 2024Carebook Technologies Inc. provided earnings guidance for the fiscal year 2024. For the period, the company continues to be positive for 2024 poised to achieve significant revenue growth.お知らせ • Aug 15Carebook Technologies Inc. to Report Q2, 2024 Results on Aug 21, 2024Carebook Technologies Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 21, 2024お知らせ • May 11Carebook Technologies Inc. to Report Q1, 2024 Results on May 15, 2024Carebook Technologies Inc. announced that they will report Q1, 2024 results at 9:30 AM, US Eastern Standard Time on May 15, 2024お知らせ • Apr 03Carebook Technologies Inc. Provides Earnings Guidance for the Full Year 2024Carebook Technologies Inc. provided earnings guidance for the full year 2024. The company's financial outlook continues to be positive for 2024. The company is poised to achieve significant revenue growth while effectively managing its costs and delivering sustained growth in cashflows. The company's strong organic growth and efficient cost management initiatives will allow the company to continue to successfully execute on its strategy.お知らせ • Apr 02Carebook Technologies Inc., Annual General Meeting, Jun 13, 2024Carebook Technologies Inc., Annual General Meeting, Jun 13, 2024.お知らせ • Mar 19Carebook Technologies Inc. to Report Fiscal Year 2023 Results on Apr 01, 2024Carebook Technologies Inc. announced that they will report fiscal year 2023 results at 9:30 AM, US Eastern Standard Time on Apr 01, 2024お知らせ • Dec 12Carebook Technologies Inc. announced that it has received CAD 2 million in funding from ICM LimitedOn December 11, 2023, Carebook Technologies Inc. closed the transaction.お知らせ • Oct 24Carebook Technologies Inc. to Report Q3, 2023 Results on Nov 10, 2023Carebook Technologies Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 10, 2023お知らせ • Aug 23Carebook Technologies Inc. Provides Earnings Guidance for the Year 2023Carebook Technologies Inc. provided earnings guidance for the year 2023. For the period, the company expects financial outlook continues to be positive for 2023. The Company is poised to achieve significant revenue growth while effectively managing its costs and delivering sustained growth in cashflows. Carebook's strong organic growth and efficient cost management initiatives will allow the Company to continue to successfully execute on its strategy. Carebook is expecting to maintain strong performance in 2023 for the entire Company as a whole.お知らせ • Aug 09Carebook Technologies Inc. to Report Q2, 2023 Results on Aug 22, 2023Carebook Technologies Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 22, 2023お知らせ • Jun 29Carebook Technologies Inc. Announces Resignation of Mathieu Lampron as Chief Product Officer and Chief Operating OfficerCarebook Technologies Inc. announced that Mathieu Lampron, Carebook's Chief Product Officer and Chief Operating Officer, has announced that after nearly 7 years with Carebook, he is leaving the Company effective June 23, 2023, to pursue another opportunity. It is currently anticipated that Mr. Lampron's former responsibilities will be assigned to existing Carebook team members and that the Company will not be seeking a replacement chief product officer or a replacement chief operating officer in the near future.お知らせ • May 24Carebook Technologies Inc. announced that it has received CAD 1.25 million in funding from ICM LimitedOn May 23, 2023, Carebook Technologies Inc. closed the transaction. The transaction has been conditionally approved by the TSX Venture Exchange (the "Exchange") and the listing of the Common Shares issued under the Transaction and the Common Shares issuable upon the exercise of the Warrants, as applicable. The Common Shares and the Warrants issued under the Transaction, as well as the Common Shares issuable upon exercise of the Warrants, are subject to a restricted period under applicable Canadian securities laws of four months and one day following the date hereof, ending on September 24, 2023.お知らせ • May 17Carebook Technologies Inc. announced that it expects to receive CAD 1.25 million in funding from ICM LimitedCarebook Technologies Inc. announced a non-brokered private placement of up to 12,500,000 units at the price of CAD 0.10 per unit for gross proceeds of up to CAD 1,250,000 on May 15, 2023. Each Unit will consist of one common share and 0.015 common share purchase warrant. Each whole Warrant will entitle its holder to acquire, on payment of CAD 0.15 to the Company, one Common Share for a period ending on the second anniversary of the Closing Date. The transaction will include participation from returning investor UIL Limited, a fund managed by ICM Limited. The closing of the transaction is subject to certain conditions, including the approval of the TSX Venture Exchange and certain other conditions customary to a transaction of this nature. All securities issued pursuant to the transaction will be subject to a statutory four month and one day hold period from the Closing Date. The transaction is expected to close on May 17, 2023.決済の安定と成長配当データの取得安定した配当: CRBK.Fの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: CRBK.Fの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Carebook Technologies 配当利回り対市場CRBK.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (CRBK.F)n/a市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Healthcare Services)1.1%アナリスト予想 (CRBK.F) (最長3年)n/a注目すべき配当: CRBK.Fは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: CRBK.Fは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: CRBK.Fの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: CRBK.Fが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/02/25 00:33終値2024/12/19 00:00収益2024/09/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Carebook Technologies Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Douglas TaylorCanaccord Genuity
お知らせ • Feb 25+ 1 more updateCarebook Technologies' Common Shares to be Delisted from the TSX Venture Exchange at the Close of Trading on or about February 25, 2025Carebook Technologies Inc. (‘Carebook’ or the ‘Company’) announced the closing of the previously announced plan of arrangement (the ‘Transaction’) pursuant to which UIL Limited (‘UIL’) has acquired all of the common shares of Carebook (the ‘Common Shares’) not already owned by UIL and its affiliates or associates, at a price of $0.10 per Common Share (the ‘Consideration’), for aggregate consideration to the shareholders of Carebook (other than UIL and its associates or associates) of $4,170,618.90. The Transaction received overwhelming support from the Company's shareholders at a special meeting held on February 18, 2025, and the Transaction received final court approval on February 20, 2025. As a result of the Transaction, the Common Shares are expected to be delisted from the TSX Venture Exchange (‘TSXV’) at the close of trading on or about February 25, 2025. The Company also intends to submit an application to cease to be a reporting issuer under applicable Canadian securities laws and to otherwise terminate the Company's public reporting requirements.
お知らせ • Jan 03UIL Limited (LSE:UTL), managed by ICM Limited entered into an arrangement agreement to acquire remaining 40.6% stake in Carebook Technologies Inc. (TSXV:CRBK) from Medtech Investment, L.P and others for CAD 4.2 million.UIL Limited (LSE:UTL), managed by ICM Limited entered into an arrangement agreement to acquire remaining 40.6% stake in Carebook Technologies Inc. (TSXV:CRBK) from Medtech Investment, L.P and others for CAD 4.2 million on January 2, 2025. UIL will acquire all of the common shares (the "Common Shares") in the capital of Carebook, other than those Common Shares already owned by UIL or its affiliates and associates, by way of a plan of arrangement (the "Arrangement"). Pursuant to the Arrangement, holders of Common Shares, other than those Common Shares already owned by UIL or its affiliates and associates, will receive CAD 0.10 per Common Share (the "Consideration"). The Consideration represents a premium of approximately 122%, to the closing price of the Common Shares of CAD 0.045 on the TSX Venture Exchange (the "TSXV") on January 2, 2025, the last trading day prior to the announcement of the Arrangement. Completion of the Arrangement is subject to court approval and various closing conditions, including the approval of at least (i) two-thirds (66 2/3%) of the votes cast by shareholders present in person or represented by proxy at the special meeting of the shareholders to be called to approve the Arrangement (the "Special Meeting") (each holder of Common Shares being entitled to one vote per Common Share) and (ii) the approval of a simple majority of the holders of Common Shares present in person or represented by proxy at the Special Meeting, excluding the votes of UIL and its affiliates and associates and any other shareholders required to be excluded for purposes of the "minority approval" requirement under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101") in the context of a "business combination" (the "Minority Shareholders"). Further details regarding applicable voting requirements will be contained in a management information circular to be filed on SEDAR+ at www.sedarplus.com and mailed to Carebook's shareholders in connection with the Special Meeting to approve the Arrangement. The signing of the Arrangement Agreement and the approval of the Arrangement followed the unanimous approval of the board of directors of the Company (the "Board") (with Alasdair Younie abstaining) following the unanimous recommendation of a committee of independent directors (the "Special Committee") of the Board. The Arrangement is expected to close in the first quarter of 2025, subject to the satisfaction of customary closing conditions. The Arrangement will be completed pursuant to a court-approved plan of arrangement under section 192 of the Canada Business Corporations Act and is subject to satisfaction of customary closing conditions for transactions of this nature, including court approval and the approval of the shareholders of Carebook, as further set out below. Immediately following the completion of the Arrangement, the Common Shares will be delisted from the TSXV and it is anticipated that the Company will make an application to cease to be a reporting issuer, following the approval of which, the Company will no longer be subject to the reporting requirements of applicable Canadian securities legislation. BDO Canada LLP is acting as financial advisor and fairness opinion provider to the Special Committee, and Stikeman Elliott LLP is acting as legal advisor to the Special Committee and the Company. Norton Rose Fulbright Canada LLP is acting as legal advisor to UIL on the proposed transaction.
お知らせ • Nov 08Carebook Technologies Inc. to Report Q3, 2024 Results on Nov 15, 2024Carebook Technologies Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 15, 2024
お知らせ • Aug 22Carebook Technologies Inc. Provides Earnings Guidance for the Fiscal Year 2024Carebook Technologies Inc. provided earnings guidance for the fiscal year 2024. For the period, the company continues to be positive for 2024 poised to achieve significant revenue growth.
お知らせ • Aug 15Carebook Technologies Inc. to Report Q2, 2024 Results on Aug 21, 2024Carebook Technologies Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 21, 2024
お知らせ • May 11Carebook Technologies Inc. to Report Q1, 2024 Results on May 15, 2024Carebook Technologies Inc. announced that they will report Q1, 2024 results at 9:30 AM, US Eastern Standard Time on May 15, 2024
お知らせ • Apr 03Carebook Technologies Inc. Provides Earnings Guidance for the Full Year 2024Carebook Technologies Inc. provided earnings guidance for the full year 2024. The company's financial outlook continues to be positive for 2024. The company is poised to achieve significant revenue growth while effectively managing its costs and delivering sustained growth in cashflows. The company's strong organic growth and efficient cost management initiatives will allow the company to continue to successfully execute on its strategy.
お知らせ • Apr 02Carebook Technologies Inc., Annual General Meeting, Jun 13, 2024Carebook Technologies Inc., Annual General Meeting, Jun 13, 2024.
お知らせ • Mar 19Carebook Technologies Inc. to Report Fiscal Year 2023 Results on Apr 01, 2024Carebook Technologies Inc. announced that they will report fiscal year 2023 results at 9:30 AM, US Eastern Standard Time on Apr 01, 2024
お知らせ • Dec 12Carebook Technologies Inc. announced that it has received CAD 2 million in funding from ICM LimitedOn December 11, 2023, Carebook Technologies Inc. closed the transaction.
お知らせ • Oct 24Carebook Technologies Inc. to Report Q3, 2023 Results on Nov 10, 2023Carebook Technologies Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 10, 2023
お知らせ • Aug 23Carebook Technologies Inc. Provides Earnings Guidance for the Year 2023Carebook Technologies Inc. provided earnings guidance for the year 2023. For the period, the company expects financial outlook continues to be positive for 2023. The Company is poised to achieve significant revenue growth while effectively managing its costs and delivering sustained growth in cashflows. Carebook's strong organic growth and efficient cost management initiatives will allow the Company to continue to successfully execute on its strategy. Carebook is expecting to maintain strong performance in 2023 for the entire Company as a whole.
お知らせ • Aug 09Carebook Technologies Inc. to Report Q2, 2023 Results on Aug 22, 2023Carebook Technologies Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 22, 2023
お知らせ • Jun 29Carebook Technologies Inc. Announces Resignation of Mathieu Lampron as Chief Product Officer and Chief Operating OfficerCarebook Technologies Inc. announced that Mathieu Lampron, Carebook's Chief Product Officer and Chief Operating Officer, has announced that after nearly 7 years with Carebook, he is leaving the Company effective June 23, 2023, to pursue another opportunity. It is currently anticipated that Mr. Lampron's former responsibilities will be assigned to existing Carebook team members and that the Company will not be seeking a replacement chief product officer or a replacement chief operating officer in the near future.
お知らせ • May 24Carebook Technologies Inc. announced that it has received CAD 1.25 million in funding from ICM LimitedOn May 23, 2023, Carebook Technologies Inc. closed the transaction. The transaction has been conditionally approved by the TSX Venture Exchange (the "Exchange") and the listing of the Common Shares issued under the Transaction and the Common Shares issuable upon the exercise of the Warrants, as applicable. The Common Shares and the Warrants issued under the Transaction, as well as the Common Shares issuable upon exercise of the Warrants, are subject to a restricted period under applicable Canadian securities laws of four months and one day following the date hereof, ending on September 24, 2023.
お知らせ • May 17Carebook Technologies Inc. announced that it expects to receive CAD 1.25 million in funding from ICM LimitedCarebook Technologies Inc. announced a non-brokered private placement of up to 12,500,000 units at the price of CAD 0.10 per unit for gross proceeds of up to CAD 1,250,000 on May 15, 2023. Each Unit will consist of one common share and 0.015 common share purchase warrant. Each whole Warrant will entitle its holder to acquire, on payment of CAD 0.15 to the Company, one Common Share for a period ending on the second anniversary of the Closing Date. The transaction will include participation from returning investor UIL Limited, a fund managed by ICM Limited. The closing of the transaction is subject to certain conditions, including the approval of the TSX Venture Exchange and certain other conditions customary to a transaction of this nature. All securities issued pursuant to the transaction will be subject to a statutory four month and one day hold period from the Closing Date. The transaction is expected to close on May 17, 2023.